StockNews.com Begins Coverage on Bio-Path (NASDAQ:BPTH)

StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report published on Monday morning. The brokerage issued a sell rating on the stock. Bio-Path Stock Down 8.2 % Shares of NASDAQ:BPTH opened at $0.42 on Monday. Bio-Path has a 12 month low of $0.32 and a 12 month high of $2.35. […]

Leave a Reply

Your email address will not be published.

Previous post ‘Migration’ doesn’t have all its ducks in a row
Next post StockNews.com Begins Coverage on Ayala Pharmaceuticals (NASDAQ:ADXS)